Evidence map›Paper›PMID 40115440›Full record

ArticleFrontiers in cardiovascular medicine2025

Temporal left ventricular ejection fraction variations and outcomes in wide population of cardiovascular patients with and without heart failure.

Radosław Szczerba, Wiktoria Żelazna, Jakub Sokołowski, Natalia Wyroba, Zuzanna Wydrych, Michał Wita, Małgorzata Cichoń, Michał Orszulak, Katarzyna Mizia-Stec, Krystian Wita and 1 more

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Radosław SzczerbaFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Wiktoria ŻelaznaFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Jakub SokołowskiFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Natalia WyrobaFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Zuzanna WydrychFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Michał WitaFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Małgorzata CichońFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Michał OrszulakFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Katarzyna Mizia-StecFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Krystian WitaFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Maciej T WybraniecFirst Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Heart failure (HF) with improved ejection fraction (HFimpEF) was shown to be related with improved outcome but increase of left ventricular ejection fraction (LVEF) in patients without HF is of less known clinical significance. The aim of the study was to evaluate long-term prognosis in patients with different cardiovascular disorders, with and without HF, depending on temporal variations of LVEF. Methods: The study covered 31 920 patients (median age 71 years, 37.7% females) with different cardiovascular disorders and at least two measurements of LVEF separated by ≥1 month. Clinical parameters were acquired from database of Academic Repository of Clinical Cases of Medical University of Silesia. HFimpEF was defined by LVEF increase ≥10% in HF patients in relation to baseline value. The endpoints were all-cause mortality and Major Adverse Cardiac and Cerebrovascular Event (MACCE). Results: The median follow-up time was 51.5 months and LVEF was measured median 2 times. HF was diagnosed in 12 152 patients (38.1%), of which 2 843 (23.4%) experienced HFimpEF. MACCE occurrence was greater in HF than non-HF patients (12.78%/year vs. 6.07%/year, Conclusions: Temporal increase of LVEF corresponds with improved survival in patients with HF but not among non-HF patients.

Indexed as

heart failureheart failure with improved ejection fractionHFimpEFleft ventricular ejection fractionMACCEmortality

Identifiers

PMID40115440
PMCPMC11922955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.